Sowell Financial Services LLC Red Hill Biopharma Ltd. Transaction History

Sowell Financial Services LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$4.55 - $10.36 $421,657 - $960,081	-92,672 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$5.98 - $7.51 $364 - $458	-61 Reduced 0.07%	92,672 $638,000
Q1 2021 May 07, 2021	BUY	$6.98 - $11.29 $36,009 - $58,245	5,159 Added 5.89%	92,733 $568,000
Q4 2020 Jan 13, 2021	BUY	$7.81 - $10.39 $30,794 - $40,967	3,943 Added 4.71%	87,574 $708,000
Q3 2020 Nov 12, 2020	SELL	$6.34 - $10.83 $6,891 - $11,772	-1,087 Reduced 1.28%	83,631 $855,000
Q2 2020 Aug 13, 2020	SELL	$4.6 - $8.6 $16,132 - $30,160	-3,507 Reduced 3.98%	84,718 $568,000
Q1 2020 May 12, 2020	BUY	$3.51 - $6.17 $187,556 - $329,693	53,435 Added 153.59%	88,225 $400,000
Q4 2019 Feb 07, 2020	BUY	$5.76 - $7.35 $42,986 - $54,853	7,463 Added 27.31%	34,790 $211,000
Q3 2019 Nov 14, 2019	BUY	$6.46 - $8.37 $176,532 - $228,726	27,327 New	27,327 $192,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.